À§¾Ï¿¡¼ Cyclooxygenase¿Í Nitric Oxide Synthase ¹ßÇö°ú Ç÷°ü½Å»ýÀÎÀÚ¿ÍÀÇ °ü°è¿¡ ´ëÇÑ ¿¬±¸
Study in the Relationship between Angiogenic Factor and Expression of Cyclooxygenase and Nitric Oxide Synthase in Gastric Cancer
ÀÌÀÍ·æ, ±è¿øÁø, ±è¹ÎÂù, Á¤°©Áß, ÃÖÈ«Á¶, °ûÁ¾¿µ, Á¶¼¼Çå, ±è¿µÈÆ, ±èÇüÈ£, ±è»ó¼ø,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÀÍ·æ ( Lee Ik-Ryong )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±è¿øÁø ( Kim Won-Jin )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇб³½Ç
±è¹ÎÂù ( Kim Min-Chan )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
Á¤°©Áß ( Jung Ghap-Joong )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÃÖÈ«Á¶ ( Choi Hong-Jo )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
°ûÁ¾¿µ ( Kwak Jong-Young )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇб³½Ç
Á¶¼¼Çå ( Joh Se-Heon )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±è¿µÈÆ ( Kim Young-Hoon )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÇüÈ£ ( Kim Hyung-Ho )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±è»ó¼ø ( Kim Sang-Sun )
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
KMID : 0371320010600010047
Abstract
Purpose: Secretion of angiogenic factors from tumor cells is know to play an important role in neo-vascularization and metastasis. However, which angiogenic factor is related with the formation of neo-vasculature in gastric carcinomas is not well known. This study was performed to observe changes in the expression of vascular endothelial growth factor (VEGF), cyclooxygenase (COX), and nitric- oxide synthase (NOS).
Methods: Expressions of VEGF, COX, and NOS in thirty specimens resected from patients with a gastric carcinoma were investigated using the western blot method. Cultured MKN28 gastric cancer cells were treated with 100 ng/ml VEGF, and changes in the expression of COX and NOS were examined. Changes in VEGF expression were also investigated after treatment of the cells with inhibitors of COX and NOS.
Results: Expressions of VEGF, COX, and eNOS were increased up to 10, 60, and 30%, respectively, in tumors compared to surrounding normal tissues. VEGF-positive tumors showed a higher expression of COX-2. Human recombinant VEGF induced the expression of COX-2, but not eNOS, in the cultured MKN28 cells. The increase in expression was blocked with actinomycin D, the VEGF antibody, and anti-VEGF peptide. VEGF-induced expression of COX-2 was also blocked by pretreatment of cells with aspirin and indomethacin,
suggesting that these anti-inflammatory drugs inhibit VEGF. The expression of eNOS was decreased by indomethacin in VEGF-treated cells, but COX-2 expression was not affected by inhibitors of NO production, N-arginine methylester (NAME). However, the protein level of VEGF was increased by indomethacin and NAME.
Conclusion: This study showed that COX-2 and eNOS in gastric carcinomas seem to play an important role in the production of VEGF and that their expressions may also be affected by VEGF.
Å°¿öµå
À§¾Ï;Ç÷°ü½Å»ý;»çÀÌÅ©·Î¿Á½ÃÁ¦³ª¾ÆÁ¦;Ç÷°ü³»ÇǼ¼Æ÷¼ºÀåÀÎÀÚ;¾Æ»êÈÁú¼Ò ÇÕ¼ºÈ¿¼Ò
Gastric cancer;Angiogenesis;Cyclooxygenase;Vascular endothelial growth factor;Nitric oxide synthase
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸